Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$858M |
| 2 |
Costco
COST
|
+$557M |
| 3 |
UnitedHealth
UNH
|
+$551M |
| 4 |
Atlassian
TEAM
|
+$489M |
| 5 |
Northrop Grumman
NOC
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$579M |
| 2 |
TSMC
TSM
|
+$433M |
| 3 |
Airbnb
ABNB
|
+$426M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$341M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.22% |
| 2 | Consumer Discretionary | 23.3% |
| 3 | Healthcare | 16.47% |
| 4 | Financials | 9.42% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
O-I Glass
OI
$1.16B
| $1.04M | ﹤0.01% |
80,331
+24,029
| +43% | +$325K |
|
502
OFG Bancorp
OFG
$2.26B
| $1.04M | ﹤0.01% |
41,349
+997
| +2% | +$27.1K |
|
503
Golar LNG
GLNG
$5.03B
| $1.03M | ﹤0.01% |
41,490
+8,187
| +25% | +$204K |
|
504
Pacific Biosciences
PACB
$447M
| $1.03M | ﹤0.01% |
177,292
+24,127
| +16% | +$138K |
|
505
Apple Hospitality REIT
APLE
$3.91B
| $1.01M | ﹤0.01% |
72,122
+14,379
| +25% | +$228K |
|
506
Urban Outfitters
URBN
$6.75B
| $1M | ﹤0.01% |
+51,148
| New | +$1.07M |
|
507
Red Rock Resorts
RRR
$3.76B
| $1M | ﹤0.01% |
+29,247
| New | +$1.11M |
|
508
American Well
AMWL
$174M
| $998K | ﹤0.01% |
13,902
-2,374
| -15% | -$208K |
|
|
TPH
509
DELISTED
Tri Pointe Homes
TPH
| $998K | ﹤0.01% |
66,056
-1,716
| -3% | -$30.3K |
|
510
Kforce
KFRC
$1.04B
| $996K | ﹤0.01% |
16,978
-10,562
| -38% | -$630K |
|
511
Cushman & Wakefield Ltd
CWK
$3.3B
| $979K | ﹤0.01% |
+85,483
| New | +$1.29M |
|
|
BSX.PRA
512
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
| $973K | ﹤0.01% |
9,616
| – | – |
|
|
BBT
513
Beacon Financial Corp
BBT
$2.71B
| $968K | ﹤0.01% |
35,471
-32,109
| -48% | -$896K |
|
514
CBIZ
CBZ
$2.99B
| $965K | ﹤0.01% |
22,567
-1,255
| -5% | -$54.9K |
|
|
ZUO
515
DELISTED
Zuora, Inc.
ZUO
| $945K | ﹤0.01% |
128,024
+43,099
| +51% | +$372K |
|
516
First Financial Bancorp
FFBC
$3.62B
| $936K | ﹤0.01% |
+44,425
| New | +$963K |
|
517
UMB Financial
UMBF
$11.3B
| $879K | ﹤0.01% |
10,428
-5,421
| -34% | -$491K |
|
518
Nelnet
NNI
$4.89B
| $874K | ﹤0.01% |
+11,040
| New | +$960K |
|
519
BridgeBio Pharma
BBIO
$16.1B
| $864K | ﹤0.01% |
+86,906
| New | +$903K |
|
520
Automatic Data Processing
ADP
$108B
| $863K | ﹤0.01% |
+3,816
| New | +$900K |
|
|
EVRI
521
DELISTED
Everi Holdings
EVRI
| $861K | ﹤0.01% |
53,112
-24,402
| -31% | -$449K |
|
522
Paylocity
PCTY
$7.67B
| $861K | ﹤0.01% |
3,563
+884
| +33% | +$203K |
|
523
First Bancorp
FBP
$4.46B
| $840K | ﹤0.01% |
61,411
-4,508
| -7% | -$65.4K |
|
|
RDFN
524
DELISTED
Redfin
RDFN
| $836K | ﹤0.01% |
143,210
+40,215
| +39% | +$357K |
|
525
Belden
BDC
$4.98B
| $827K | ﹤0.01% |
13,787
-9,018
| -40% | -$574K |
|
Similar funds
Jennison Associates's Q3 2022 Portfolio in Review
As of Q3 2022, Jennison Associates held 689 positions worth $101B, up 0.37% from $100B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates's Q3 2022 filing shows 75 new, 294 increased, 218 reduced and 90 closed positions. Its largest new stake was T-Mobile US: 1,657,443 shares worth $222M. The largest sale was Nike, an estimated $579M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2022 buy was T-Mobile US: 1,657,443 shares worth $222M.
- Jennison Associates added most to Vertex Pharmaceuticals in Q3 2022, an estimated $858M increase.
- Jennison Associates's biggest Q3 2022 reduction was Nike, cutting an estimated $579M.
- Jennison Associates fully exited Snap in Q3 2022, selling an estimated $197M.
- Jennison Associates's ten largest holdings make up 40% of its $101B portfolio in Q3 2022.
- Jennison Associates opened 75 new positions and closed 90 in Q3 2022.
- Jennison Associates's portfolio value rose 0.37% quarter-over-quarter to $101B.
Based on Jennison Associates's 13F filing for Q3 2022, filed 1 Nov 2022.